Clinical trial
Prevention of Severe Anaemia in Gambian Children
NCT00131716 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00131716 |
|---|---|
| Title | Prevention of Severe Anaemia in Gambian Children |
| Official title | Chemoprophylaxis With Sulfadoxine-pyrimethamine to Prevent Recurrence of Severe Anaemia in Gambian Children Aged 3 Months to 9 Years |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Collaborators | Department of State for Health and Social Welfare, The Gambia |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | sulfadoxine-pyrimethamine |
| Enrollment | 1,200 |
| Start date | May 1, 2003 |
| Completion | May 1, 2005 |
| First posted | Aug 19, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | The Gambia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: